Intellipharmaceutics
30 Worcester Road
Toronto
Ontario
M9W 5X2
Canada
Tel: 416-798-3001
Fax: 416-798-3007
Website: http://www.intellipharmaceutics.com/
163 articles about Intellipharmaceutics
-
Intellipharmaceutics Announces Launch Of Generic Seroquel XR By Mallinckrodt
6/6/2017
-
Intellipharmaceutics Files Preliminary Base Shelf Prospectus And Shelf Registration Statement To Replace Expiring Shelf Registration Statement
5/30/2017
-
Intellipharmaceutics Reports On Launch Of Additional Strengths Of Generic Focalin XR By Par Pharma
5/25/2017
-
Intellipharmaceutics Announces FDA Final Approval Of Generic Seroquel XR
5/11/2017
-
Intellipharmaceutics Reports Director Election Results
4/19/2017
-
Intellipharmaceutics Announces First Quarter 2017 Results
4/12/2017
-
Intellipharmaceutics Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone
4/10/2017
-
IntelliPharmaCeutics Announces TSX Trading Symbol Change To “IPCI”
3/16/2017
-
IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Glucophage XR
2/24/2017
-
IntelliPharmaCeutics Announces 2016 Year End Results
2/10/2017
-
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain
2/3/2017
-
IntelliPharmaCeutics Reports On Launch Of Additional Strengths Of Generic Focalin XR By Par Pharma
1/6/2017
-
IntelliPharmaCeutics Announces Issuance Of U.S. And Canadian Patents Covering Aspects Of Its PODRAS Overdose Technology
12/21/2016
-
IntelliPharmaCeutics Submits New Drug Application For Rexista® (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain
11/28/2016
-
IntelliPharmaCeutics Announces Third Quarter 2016 Results
10/14/2016
-
IntelliPharmaCeutics Signs An Exclusive License And Commercial Supply Agreement With Mallinckrodt
10/12/2016
-
IntelliPharmaCeutics Announces FDA Tentative Approval for Generic Seroquel XR
10/10/2016
-
IntelliPharmaCeutics Responds To Recent Trading Activity
9/23/2016
-
IntelliPharmaCeutics To Present At The 18th Annual Rodman & Renshaw Global Investment Conference
8/26/2016
-
IntelliPharmaCeutics Announces Second Quarter 2016 Results
7/13/2016